Public health
COVID-19
Vaccine tests advance
One of the best-known COVID-19 vaccine candidates achieved good results in the first phase of clinical trials
By Redação
Cover
Difficult exit
Quarantine relaxation strategies differ around the country
By Yuri Vasconcelos and Rubem Barros
COVER
Saving time
Brazilian research centers negotiate deals to import vaccine production technology
COVID-19
A SARS-CoV-2-proof fabric
Researchers from São Paulo–based company Nanox have developed a fabric containing silver nanoparticles that can inactivate the novel coronavirus, SARS-CoV-2
By Redação
COVID-19
Platform gathers data on Brazilians with COVID-19
The COVID-19 Data Sharing/BR platform is a repository of clinical, laboratory and demographic data on people diagnosed with the infection in the country
By Redação
Pandemic
3.1 million lives saved in Europe
The strict social distancing and lockdown measures implemented in 11 European countries before May 4 may have prevented 3.1 million COVID-19 deaths
By Redação
Data
FAPESP funds COVID-19 research projects
Number of projects at each institution (as of 06/18/2020)
By Redação
Cover
Calculating in the dark
Creativity helps scientists predict the economic impacts of an unprecedented crisis
By Diego Viana
Cover
The reality of data
Mapping and systematizing COVID-19 data is crucial to controlling the disease in Brazil
By Redação
Covid-19
Traditional Chinese medicine to treat COVID-19
China's government and state media are encouraging the use of traditional medicines and remedies to treat COVID-19, despite the lack of scientific support
By Redação
COVID-19
Novel coronavirus can damage the retina
Ophthalmologists at the Federal University of São Paulo suspect that Sars-CoV-2, the virus that causes COVID-19, can damage the retina
By Redação
Covid-19
Growing lung cells
São Paulo–based startup TissueLabs has created a platform that mimics the environment of the pulmonary epithelium to allow scientists to study how the SARS-CoV-2 virus, which causes COVID-19, affects the lungs
By Redação
Data
At least 125 COVID-19 vaccines are in development, with 10 already undergoing clinical trials
Vaccines in the clinical trials phase worldwide and in development in Brazil (as of May 27, 2020)
By Redação
Letter from the Editor | 292
Crucial numbers
Little is known about viruses. Existing on the boundary between the living and the nonliving, they are found in all environments where there is life. Their effects on living beings can be beneficial, harmless, or capable of triggering devastating epidemics, such as Ebola, Zika, and now, SARS-CoV-2. Although the number of species is estimated in... View Article